SEC 13F Intelligence

Managers / Q3 2022

Parian Global Management LP

CIK 0001752148 · 61 POUND RIDGE ROAD, POUND RIDGE, NY, 10576 · 212-466-6961

Reported Value
$31M
Q3 2022
Positions
32
Filings on Record
16
2019–present window
Filed
Nov 14, 2022
original filing

Summary

Parian Global Management LP reported $31M in U.S.-listed holdings across 32 positions for Q3 2022.

Its largest position, CVRX, represents 11.9% of the portfolio.

Compared with Q2 2022, the fund opened 20 new positions and exited 0.

Portfolio Metrics

Turnover
+18.7%
vs prior filed quarter
Top-10 Concentration
+72.2%
share of reported value
Largest Position
+11.9%
Cvrx

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $144MQ1 ’19Q2 ’19: $154MQ3 ’19: $221MQ3 ’19Q4 ’19: $445MQ1 ’20: $284MQ1 ’20Q2 ’20: $383MQ3 ’20: $315MQ3 ’20Q4 ’20: $400MQ1 ’21: $219MQ1 ’21Q2 ’21: $233MQ3 ’21: $143MQ3 ’21Q4 ’21: $125MQ1 ’22: $49MQ1 ’22Q2 ’22: $22MQ3 ’22: $31MQ3 ’22filingsflow.com

Portfolio Composition

By security type
Common Stock: 93.2%Other: 6.0%ADR: 0.8%
  • Common Stock · 93.2% · $29M
  • Other · 6.0% · $2M
  • ADR · 0.8% · $237,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
NOTVQINOTIV INCNEW+136.9K136.9K+$2M$2M
AIRSAIRSCULPT TECHNOLOGIES INCNEW+165.0K165.0K+$1M$1M
TKNOALPHA TEKNOVA INCNEW+290.0K290.0K+$969,000$969,000
VRAYQVIEWRAY INCNEW+265.0K265.0K+$965,000$965,000
ACVAACV AUCTIONS INCNEW+87.5K87.5K+$629,000$629,000
GFFGRIFFON CORPNEW+21.0K21.0K+$620,000$620,000
AVID BIOSERVICES INCNEW+31.0K31.0K+$593,000$593,000
NRDSNERDWALLET INCNEW+60.0K60.0K+$532,000$532,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

32 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CVRXCVRX INChistory →COM11.93%$4M393.2K
2APOLLO ENDOSURGERY INCCOM9.44%$3M527.1K
3IRTCIRHYTHM TECHNOLOGIES INChistory →COM9.29%$3M22.8K
4STIMNEURONETICS INChistory →COM8.59%$3M830.3K
5ATECALPHATEC HLDGS INChistory →COM NEW7.56%$2M265.9K
6NOTVQINOTIV INChistory →COM7.50%$2M136.9K
7VAPOTHERM INCCOM6.00%$2M1.18M
8STXSSTEREOTAXIS INChistory →COM NEW4.81%$1M821.1K
9TOITHE ONCOLOGY INSTITUTE INChistory →COM3.63%$1M240.7K
10AIRSAIRSCULPT TECHNOLOGIES INChistory →COM3.45%$1M165.0K
11NTRANATERA INChistory →COM3.42%$1M24.0K
12TKNOALPHA TEKNOVA INChistory →COM3.15%$969,000290.0K
13VRAYQVIEWRAY INChistory →COM3.14%$965,000265.0K
14ACVAACV AUCTIONS INChistory →COM CL A2.04%$629,00087.5K
15GFFGRIFFON CORPhistory →COM2.02%$620,00021.0K
16AVID BIOSERVICES INCCOM1.93%$593,00031.0K
17NRDSNERDWALLET INChistory →COM CL A1.73%$532,00060.0K
18FETFORUM ENERGY TECHNOLOGIES INhistory →COM1.52%$467,00022.0K
19BKDBROOKDALE SR LIVING INChistory →COM1.34%$413,00096.6K
20CARDIOVASCULAR SYS INC DELCOM0.99%$305,00022.0K
21PARAGON 28 INCCOM0.94%$289,00016.2K
22BERKELEY LTS INCCOM0.83%$254,00089.0K
23SERASERA PROGNOSTICS INCCLASS A COM0.79%$243,000151.7K
24RENALYTIX PLCADS0.77%$237,000184.8K
25THE BEAUTY HEALTH COMPANYCOM CL A0.64%$196,00016.6K
26MASS908 DEVICES INCCOM0.54%$165,00010.0K
27RPIDRAPID MICRO BIOSYSTEMS INCCLASS A COM0.42%$129,00040.0K
28ADMAADMA BIOLOGICS INCCOM0.40%$122,00050.0K
29QTRXQUANTERIX CORPCOM0.38%$118,00010.7K
30OPRXOPTIMIZERX CORPCOM NEW0.34%$104,0007.0K
31CVEOCIVEO CORP CDACOM NEW0.33%$101,0004.0K
32CDXSCODEXIS INCCOM0.17%$53,0008.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2022$31M32Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$22M12Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$49M12May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$125M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$143M32Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$233M44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$219M34May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020REVEALED$400M54Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$315M31Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$383M36Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$284M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$445M44Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$221M30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$154M17Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$144M17May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.